Mostrando 6 resultados de: 6
Publisher
Afinidad(1)
Chemical Biology and Drug Design(1)
Current Topics in Medicinal Chemistry(1)
Drug Testing and Analysis(1)
Molecular Diversity(1)
Área temáticas
Farmacología y terapéutica(4)
Química analítica(2)
Arquitectura del paisaje (Paisajismo)(1)
Bioquímica(1)
Ingeniería química(1)
Área de conocimiento
Bioquímica(5)
Relación cuantitativa estructura-actividad(4)
Ciencias de la computación(2)
Enzima(1)
Farmacología(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(6)
ODS 9: Industria, innovación e infraestructura(5)
ODS 10: Reducción de las desigualdades(1)
Origen
scopus(6)
Bond-based 2D Quadratic fingerprints in QSAR studies: Virtual and in vitro tyrosinase inhibitory activity elucidation
ArticleAbstract: In this report, we show the results of quantitative structure-activity relationship (QSAR) studies oPalabras claves:Bond-based quadratic indices, LDA-Based QSAR Model, lignan, ToMoCoMD-CARDD software, Tyrosinase inhibitorAutores:Abad C., Gerardo M. Casañola-Martin, Khan M.T.H., Khan S., Pérez-Jiménez F., Rescigno A., Torrens F., Yovani Marrero-PonceFuentes:scopusQSAR-based CMs and TOMOCOMD-CARD approach for the discovery of new tyrosinase inhibitor chemicals
Book PartAbstract: Tyrosinase is an oxidoreductase enzyme (EC 1.14.18.1) involved in the two mainsteps of the biochemicPalabras claves:Quantitative Structure-Activity relationship (QSAR), ToMoCoMD-CARDD, Tyrosinase inhibitorAutores:Abad C., Gerardo M. Casañola-Martin, Khan M.T.H., Rescigno A., Thu H.L.T., Torrens F., Yovani Marrero-PonceFuentes:scopusNovel coumarin-based tyrosinase inhibitors discovered by OECD principles-validated QSAR approach from an enlarged, balanced database
ArticleAbstract: The present work is devoted to the development and application of a multi-agent Quantitative StructuPalabras claves:Atom-based bilinear index, coumarin, In silico identification, In vitro corroboration, linear discriminant analysis, OECD principle, QSAR model, ToMoCoMD-CARDD software, Tyrosinase inhibitorAutores:Abad C., Gerardo M. Casañola-Martin, Parmar V.S., Rescigno A., Saso L., Thu H.L.T., Torrens F., Yovani Marrero-PonceFuentes:scopusTyrosinase enzyme: 1. An overview on a pharmacological target
ArticleAbstract: The tyrosinase enzyme (EC 1.14.18.1) is an oxidoreductase inside the general enzyme classification aPalabras claves:Hyperpigmentation, melanin, Molecular mechanism, Structure, TyrosinaseAutores:Abad C., Garit J., Gerardo M. Casañola-Martin, Khan M.T.H., Rescigno A., Thu H.L.T., Torrens F., Yovani Marrero-PonceFuentes:scopusTyrosinase enzyme: 2. Inhibitors from natural and synthetic origins
ArticleAbstract: In this work there are tackled in a general way the tyrosinase inhibitor compounds, the limiting enzPalabras claves:drugs, Natural products, Synthetic compounds, Tyrosinase inhibitorsAutores:Abad C., Gerardo M. Casañola-Martin, Khan M.T.H., Rescigno A., Thu H.L.T., Torrens F., Yovani Marrero-PonceFuentes:scopusVanilloid Derivatives as Tyrosinase Inhibitors Driven by Virtual Screening-Based QSAR Models
ArticleAbstract: A number of vanilloids have been tested as tyrosinase inhibitors using Ligand-Based Virtual ScreeninPalabras claves:Ligand-Based Virtual Screening (LBVS), Quantitative Structure-Activity relationship (QSAR), Tyrosinase inhibitionAutores:Gerardo M. Casañola-Martin, Rescigno A., Sanjust E., Yovani Marrero-Ponce, Zucca P.Fuentes:scopus